CROs Hoping for Research Burst in Second Half of 2003

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2003
Volume 27
Issue 9

CROs and contract manufacturers had a decent second quarter, but they are hoping that Big Pharma comes through with a burst of trial start-ups in the second half of 2003.

External Link - article-70123.pdf

Articles in this issue
September 2003
In the Spotlight September 2003
Counterfeiting, Compliance, and Controls
September 2003
The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride
Disposable Filtration Lightens Cleaning and Validation Load
CROs Hoping for Research Burst in Second Half of 2003
Positron Emission Particle Tracking Studies of a Wurster Process for Coating Applications
Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content
Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Patrick Lavery
May 15th 2025
Article

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
May 6th 2025
Article

The shift toward personalized medicines poses new challenges in cleanroom protocols.

Image Credit: © Kiattisak – stock.adobe.com

Authentic Intelligence: Finding Diverse Talent in the Age of AI

Patrick Lavery
May 4th 2025
Article

The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity is being embraced, AI beckons as a new challenge.